Equity Asia Weekly Research - 11 Oct 2017
Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAPWhat's new from last week• Although ASX remains within its 3-month...
287 Views
Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down
We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...
503 Views
Popular and Unpopular Names in Japan in September....
We looked at September to see which names pick up the most Analyst upgrades and which names had the most Analyst downgrades. Fast Retailing Co Ltd...
181 Views
Leakage Report - 5/9/17 - Showa Shell up on Almost 7 Standard Deviations of Volume....
After the 48 volume spikes on Monday, things got back to normal yesterday with only 6 names spiking on volume. The biggest standout is Showa Shell...
199 Views
Sosei & Kyowa Hakko Kirin: Positive News on GPCR Drugs
Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...
297 Views